Inventor · disambiguated record
Neil S. Cutshall
Also filed as: CUTSHALL NEIL S · CUTSHALL NEIL SCOTT
26 granted patents·25 pending applications·141 citations·filing 2001–2025
96Inventor score
Top patents by PatentIndex Score
51 records- 0195US12030853B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2020·Granted Jul 9, 2024·4 cites·14 claims
- 0292US11661418B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2020·Granted May 30, 2023·4 cites·21 claims
- 0391US8343970B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2011·Granted Jan 1, 2013·12 cites·42 claims
- 0491US7786139B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2008·Granted Aug 31, 2010·16 cites·13 claims
- 0590US11807641B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2020·Granted Nov 7, 2023·2 cites·18 claims
- 0690US8377930B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2009·Granted Feb 19, 2013·11 cites·16 claims
- 0790US6777432B1Pharmaceutical uses and synthesis of nicotinamidesDARWIN MOLECULAR CORP·Filed 2002·Granted Aug 17, 2004·22 cites·50 claims
- 0889US12195427B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2022·Granted Jan 14, 2025·1 cites·18 claims
- 0989US8685975B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2012·Granted Apr 1, 2014·8 cites·40 claims
- 1089US8278327B2PDE10 inhibitors and related compositions and methodsBERGMANN JOHN E·Filed 2010·Granted Oct 2, 2012·14 cites·16 claims
- 1187US11584714B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2019·Granted Feb 21, 2023·5 cites·13 claims
- 1287US6562854B2Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2001·Granted May 13, 2003·19 cites·16 claims
- 1385US9434707B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2015·Granted Sep 6, 2016·3 cites·1 claims
- 1483US9102643B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2014·Granted Aug 11, 2015·3 cites·1 claims
- 1583US2024351980A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 1683US2025129020A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 1783US2025011323A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 1883US2024317682A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 1983US2024391917A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 2078US9493447B2Optically active PDE10 inhibitorOMEROS CORP·Filed 2015·Granted Nov 15, 2016·3 cites·6 claims
- 2178US9119822B2Use of PDE7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2013·Granted Sep 1, 2015·3 cites·37 claims
- 2277US7151112B1Pharmaceutical uses and synthesis of nicotinamidesUCB SA·Filed 2003·Granted Dec 19, 2006·6 cites·2 claims
- 2376US8637528B2Use of PDE7 inhibitors for the treatment of movement disordersBERGMANN JOHN E·Filed 2009·Granted Jan 28, 2014·3 cites·52 claims
- 2476US2024307537A1Methods and Compositions for Treating CancerOMEROS CORP·Filed 2023·Application pending·0 cites
- 2575US12486278B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2023·Granted Dec 2, 2025·0 cites·19 claims
- 2675US2025243198A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2025·Application pending·0 cites
- 2775US2025197349A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2025·Application pending·0 cites
- 2874US2025376443A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2025·Application pending·0 cites
- 2972US9650368B2Processes and intermediates for the preparation of a PDE10 inhibitorOMEROS CORP·Filed 2015·Granted May 16, 2017·1 cites·77 claims
- 3071US2025368604A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2025·Application pending·0 cites
- 3169US12110288B2MASP-2 inhibitors and methods of useOMEROS CORP·Filed 2020·Granted Oct 8, 2024·0 cites·17 claims
- 3268US2023321083A1Inhibitors of GPR174 and Uses ThereofOMEROS CORP·Filed 2022·Application pending·0 cites
- 3367US2025066383A1Pde 7 modulator compoundsOMEROS CORP·Filed 2024·Application pending·0 cites
- 3465US2025122225A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2024·Application pending·0 cites
- 3563US7141590B2Pharmaceutical uses and synthesis of nicotinanilide-N-oxidesUCB SA·Filed 2001·Granted Nov 28, 2006·1 cites·4 claims
- 3663US2020276190A1Inhibitors of GPR174 and Uses ThereofOMEROS CORP·Filed 2019·Application pending·0 cites
- 3762US10106516B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2016·Granted Oct 23, 2018·0 cites·12 claims
- 3862US2024228499A1Masp-2 inhibitors and methods of useOMEROS CORP·Filed 2023·Application pending·0 cites
- 3962US2020345725A1Methods and Compositions for Treating CancerOMEROS CORP·Filed 2020·Application pending·0 cites
- 4059US9783521B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2013·Granted Oct 10, 2017·0 cites·33 claims
- 4159US2008260643A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2008·Application pending·0 cites
- 4256US2010063105A1Pharmaceutical uses and synthesis of nicotinanilide-n-oxidesUCB SA·Filed 2006·Application pending·0 cites
- 4355US2018118711A1Pde10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2017·Application pending·0 cites
- 4455US2019183824A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2018·Application pending·0 cites
- 4554US2005026965A1Pharmaceutical uses and synthesis of nicotinanilide-N-oxidesDARWIN DISCOVERY LTD·Filed 2004·Application pending·0 cites
- 4652US2018057484A1Processes and intermediates for the preparation of a pde10 inhibitorOMEROS CORP·Filed 2017·Application pending·0 cites
- 4749US9850238B2Optically active PDE10 inhibitorOMEROS CORP·Filed 2016·Granted Dec 26, 2017·0 cites·9 claims
- 4848US2011091388A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2010·Application pending·0 cites
- 4946US2003212120A1Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 5046US2016015715A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →